Clinical trial
Study of E7389 in Patients With Advanced Solid Tumors
NCT00069264 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00069264 |
|---|---|
| Title | Study of E7389 in Patients With Advanced Solid Tumors |
| Official title | A Phase I Dose-Finding Study of E7389 (Halichondrin B Analog) in Patients With Advanced Solid Tumors |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Advanced Solid Tumors |
| Intervention type | Drug |
| Interventions | E7389 |
| Enrollment | 33 |
| Start date | Sep 1, 2003 |
| Primary completion | Mar 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Sep 24, 2003 |
| Last update posted | Dec 20, 2011 |
| Countries | United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: